Drugs offer diabetes hope

The possibility of a cure for type 1 diabetes continues to be discussed, with scientists now revealing a combination of two drugs that could perhaps reverse type 1 diabetes. The implications of this claim are enormous, and could radically change the daily routine of insulin injections and a strict diet that millions of diabetes patients worldwide have to adhere to.
The cocktail of drugs has been successfully employed in animal testing, and each of the drugs are separately undergoing human clinical trials. The drugs were developed by a team of scientists in California, at the La Jolla Institute for Allergy and Immunology in San Diego .
The drugs mix together something called a monoclonal antibody and a peptide. The antibody soothes the immune system whilst the peptide protects the insulin-producing cells. The drugs have worked in mice, with few side effects and a high incidence of reversing diabetes. Previous studies of the monoclonal antibody revealed a similar reversing effect, but diabetes returned. With the peptide thrown into the mix, the effects are much greater.
The mixture would not need to be injected, and holds great hope for the future.